What To Watch For In 1st Paragard Bellwether Trial
Drugmaker Teva is set to face its first bellwether trial starting Tuesday in a multidistrict litigation containing thousands of claims that the Paragard copper IUD was prone to breaking and leaving...To view the full article, register now.
Already a subscriber? Click here to view full article